J&J Hits Another Myeloma Milestone With FDA Approval Of Talvey
First Approved GPRC5D-Directed Therapy
The approval gives the company’s products a key presence in the myeloma space from the point of diagnosis and into later lines of disease.
The approval gives the company’s products a key presence in the myeloma space from the point of diagnosis and into later lines of disease.